Court Order Could Convolute Emergency Contraception Market
This article was originally published in The Tan Sheet
Executive Summary
A federal appeals court mandates full OTC sales of two-tablet levonorgestrel products, as requested in a 2001 citizen petition. The order delineates two-dose emergency contraceptives from Teva’s Plan B One-Step product, which did not exist at the time of the petition.
You may also be interested in...
In Brief
Abbott maintains diversified businesses course; citizen petition not germane to Plan B One-Step, DoJ says; Matrix noni and silver claims flagged by FDA; FDA warns e-commerce firm on claims; FDA finalizes imported food reporting rule; and Euromonitor predicts Indonesian growth spurt.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.